Reports Q3 revenue $154.2M, consensus $142.12M. “With healthcare costs rising dramatically, our mission to automate care delivery has never been more urgent,” said Daniel Perez, Co-Founder and CEO, Hinge Health (HNGE). “This quarter we surpassed 1.5 million lifetime members, delivered year-over-year revenue growth of 53%, and generated record free cash flow. Our AI-powered platform is transforming care at scale, increasing engagement for our members and reducing healthcare costs for our clients.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Hinge Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating
- Hinge Health target raised, added to ‘Tactical Outperform’ list at Evercore ISI
- Strong Buy Recommendation for Hinge Health, Inc. Amid Market Underestimation and Strategic Growth Potential
- Hinge Health price target raised to $67 from $57 at Morgan Stanley
- Hinge Health: Strong Buy Rating Driven by AI Innovation and Operational Efficiency